Fig. 1From: Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein–Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinomaKaplan–Meier distant metastasis-free survival curves for patients with N1 nasopharyngeal carcinoma stratified by a gross tumor volume of lymph node (GTVnd), b serum Epstein–Barr virus (EBV) DNA copy number, and c prognostic model. Low risk: EBV DNA ≤ 4000 copies/mL regardless of GTVnd; moderate risk: GTVnd ≤ 18.9 mL with EBV DNA > 4000 copies/mL; high risk: GTVnd > 18.9 mL with EBV DNA > 4000 copies/mL. DMFS distant metastasis-free survivalBack to article page